日本語English简体中文 繁體中文

02256 Abbisko Cayman LimitedABBISKO-BHong Kong Stock Exchange

4 posts

Abbisko Cayman Limited (02256) at a glance

Code
02256
Company
Abbisko Cayman Limited
Local name
ABBISKO-B
Market
Hong Kong Stock Exchange
Share price
HK$7.04 -0.50 (-6.70%) Oct 22 close

Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.

Abbisko Cayman Limited (02256) Stock Price HistoryNear a 52-week low

Abbisko Cayman Limited closed at HK$7.04 on Oct 22, 2026, −22.6% over 1 month, −54.0% over 1 year.

2026-09-22 中間報告書 2026 INTERIM REPORT2026-10-21 事業の状況 VOLUNTARY ANNOUNCEMENT - ABBISKO THERAPEUTICS' LAVENGRATINIB (ABSK06…HK$9.26HK$7.04Sep 22Oct 22
Price5-day MA25-day MAHang Seng IndexDisclosures
1-Month HighHK$9.26Sep 23
1-Month LowHK$7.04Oct 22
1-Week Change−3.2%vs Oct 15
1-Month Change−22.6%vs Sep 22

If you had invested HK$10,000 1 month ago, it would be worth HK$7,744 today (−22.6%).Price change only; dividends and fees are not included.

Over the same period the Hang Seng Index moved −8.6%, while this stock moved −22.6%.

Last 10 Trading Days

DateCloseChange% Change
Oct 22 (Thu)HK$7.04−0.51−6.70%
Oct 21 (Wed)HK$7.54−0.04−0.53%
Oct 20 (Tue)HK$7.58−0.17−2.19%
Oct 16 (Fri)HK$7.75+0.48+6.60%
Oct 15 (Thu)HK$7.27−0.17−2.28%
Oct 14 (Wed)HK$7.44−0.27−3.56%
Oct 13 (Tue)HK$7.72+0.01+0.19%
Oct 12 (Mon)HK$7.70−0.19−2.41%
Oct 9 (Fri)HK$7.89−0.22−2.65%
Oct 8 (Thu)HK$8.11−0.56−6.41%
2026-09-17 臨時株主総会の結果 POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON SE…2026-09-21 事業の状況 VOLUNTARY ANNOUNCEMENT - ABBISKO THERAPEUTICS ANNOUNCES POSITIVE PRE…2026-09-22 中間報告書 2026 INTERIM REPORT2026-10-21 事業の状況 VOLUNTARY ANNOUNCEMENT - ABBISKO THERAPEUTICS' LAVENGRATINIB (ABSK06…HK$11.32HK$7.04Jul 22Oct 22
Price5-day MA25-day MAHang Seng IndexDisclosures
3-Month HighHK$11.32Aug 11
3-Month LowHK$7.04Oct 22
1-Month Change−22.6%vs Sep 22
3-Month Change−33.3%vs Jul 22

If you had invested HK$10,000 3 months ago, it would be worth HK$6,675 today (−33.3%).Price change only; dividends and fees are not included.

Over the same period the Hang Seng Index moved −7.9%, while this stock moved −33.3%.

Last 10 Trading Days

DateCloseChange% Change
Oct 22 (Thu)HK$7.04−0.51−6.70%
Oct 21 (Wed)HK$7.54−0.04−0.53%
Oct 20 (Tue)HK$7.58−0.17−2.19%
Oct 16 (Fri)HK$7.75+0.48+6.60%
Oct 15 (Thu)HK$7.27−0.17−2.28%
Oct 14 (Wed)HK$7.44−0.27−3.56%
Oct 13 (Tue)HK$7.72+0.01+0.19%
Oct 12 (Mon)HK$7.70−0.19−2.41%
Oct 9 (Fri)HK$7.89−0.22−2.65%
Oct 8 (Thu)HK$8.11−0.56−6.41%
2026-09-17 臨時株主総会の結果 POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON SE…2026-09-21 事業の状況 VOLUNTARY ANNOUNCEMENT - ABBISKO THERAPEUTICS ANNOUNCES POSITIVE PRE…2026-09-22 中間報告書 2026 INTERIM REPORT2026-10-21 事業の状況 VOLUNTARY ANNOUNCEMENT - ABBISKO THERAPEUTICS' LAVENGRATINIB (ABSK06…HK$14.23HK$7.04Apr 22Oct 22
Price25-day MA75-day MAHang Seng IndexDisclosures
6-Month HighHK$14.23Apr 22
6-Month LowHK$7.04Oct 22
3-Month Change−33.3%vs Jul 22
6-Month Change−50.6%vs Apr 22

If you had invested HK$10,000 6 months ago, it would be worth HK$4,944 today (−50.6%).Price change only; dividends and fees are not included.

Over the same period the Hang Seng Index moved −12.3%, while this stock moved −50.6%.

Monthly Closes

MonthMonth-End CloseMonthly %
Oct 2026HK$7.04−21.2%
Sep 2026HK$8.93+0.5%
Aug 2026HK$8.89−11.9%
Jul 2026HK$10.09−6.1%
Jun 2026HK$10.75+10.3%
May 2026HK$9.75−24.5%
Apr 2026HK$12.92+6.9%
2026-09-17 臨時株主総会の結果 POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON SE…2026-09-21 事業の状況 VOLUNTARY ANNOUNCEMENT - ABBISKO THERAPEUTICS ANNOUNCES POSITIVE PRE…2026-09-22 中間報告書 2026 INTERIM REPORT2026-10-21 事業の状況 VOLUNTARY ANNOUNCEMENT - ABBISKO THERAPEUTICS' LAVENGRATINIB (ABSK06…HK$15.28HK$7.04Oct 22Oct 22
Price25-day MA75-day MAHang Seng IndexDisclosures
52-Week HighHK$15.28Oct 22
52-Week LowHK$7.04Oct 22
Year to Date−46.3%vs Dec 30
From 52-Week High−54.0%Oct 22

If you had invested HK$10,000 1 year ago, it would be worth HK$4,604 today (−54.0%).Price change only; dividends and fees are not included.

Over the same period the Hang Seng Index moved −11.0%, while this stock moved −54.0%.

Monthly Closes

MonthMonth-End CloseMonthly %
Oct 2026HK$7.04−21.2%
Sep 2026HK$8.93+0.5%
Aug 2026HK$8.89−11.9%
Jul 2026HK$10.09−6.1%
Jun 2026HK$10.75+10.3%
May 2026HK$9.75−24.5%
Apr 2026HK$12.92+6.9%
Mar 2026HK$12.09−4.9%
Feb 2026HK$12.71+1.7%
Jan 2026HK$12.50−4.7%
Dec 2025HK$13.11−8.3%
Nov 2025HK$14.30−1.8%
Oct 2025HK$14.56―
HK$18.21HK$2.27Oct 23, 2023Oct 22, 2026
Price13-week MA26-week MAHang Seng Index
3-Year HighHK$18.21Sep 1, 2025
3-Year LowHK$2.27Jan 29, 2024
Annualized Return+39.4%
Max Drawdown−61.4%

If you had invested HK$10,000 3 years ago, it would be worth HK$27,058 today (+170.6%).Price change only; dividends and fees are not included.

Over the same period the Hang Seng Index moved +31.8%, while this stock moved +170.6%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)HK$7.04−46.3%
2025HK$13.11―
HK$18.21HK$2.27Oct 25, 2021Oct 22, 2026
Price13-week MA26-week MAHang Seng Index
5-Year HighHK$18.21Sep 1, 2025
5-Year LowHK$2.27Jan 29, 2024
Annualized Return−9.8%
Max Drawdown−81.8%

If you had invested HK$10,000 5 years ago, it would be worth HK$5,972 today (−40.3%).Price change only; dividends and fees are not included.

Over the same period the Hang Seng Index moved −9.6%, while this stock moved −40.3%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)HK$7.04−46.3%
2025HK$13.11―

Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Oct 2021). Please check the latest prices before trading.

Recent announcements (HKEXnews)

Posts

This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.

No.4 Disclosure 2026/10/21 13:00
事業の状況
VOLUNTARY ANNOUNCEMENT - ABBISKO THERAPEUTICS' LAVENGRATINIB (ABSK061) FOR THE TREATMENT OF ACHONDROPLASIA GRANTED ORPHAN DESIGNATION BY EMA
Delete
No.3 Disclosure 2026/09/22 17:30
中間報告書
2026 INTERIM REPORT
Delete
No.2 Disclosure 2026/09/21 09:00
事業の状況
VOLUNTARY ANNOUNCEMENT - ABBISKO THERAPEUTICS ANNOUNCES POSITIVE PRELIMINARY PHASE II RESULTS WITH LAVENGRATINIB (ABSK061) FOR THE TREATMENT OF ACHONDROPLASIA
Delete
No.1 Disclosure 2026/09/17 22:35
臨時株主総会の結果
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON SEPTEMBER 17, 2026
Delete

Write on the Abbisko Cayman Limited board

You will need this to delete your post. Please keep it safe.
By posting you agree to the board rules (Japanese). You are responsible for what you write.

More Chinese stocks in English

Chinese Stock Message Board: stocks available in English

Other boards in English